Author:
Pangkahila Evert Solomon,Setiawan William Alexander
Abstract
Up to 10% of all pregnancies in the US are complicated by diabetes. Among them, 0.2 to 0.5 % of the individuals had type 1 diabetes (T1DM). Preterm birth, preeclampsia, macrosomia, shoulder dystocia, intrauterine fetal death, fetal growth restriction, cardiac and renal abnormalities, as well as uncommon neural disorders including sacral agenesis, are all heightened risks for pregnancies affected by T1DM. It has been demonstrated that preconception planning and intensive glycemic control can lower the rate of fetal loss and abnormalities in pregnancies complicated by T1DM. The number of alternatives available to the obstetric team has risen as a result of recent improvements in insulin formulations and delivery techniques. To promote compliance and guarantee optimal glucose control, insulin regimens should be customized for each patient. For effective care, intensive preconception counseling with regular follow-up visits that emphasize strict glucose control is advised.
Publisher
European Open Science Publishing
Reference21 articles.
1. International Diabetes Federational. IDF Atlas. 8th Edition 2017. [Internet] 2017 [cited 2019 June 19] Available from: https://diabetesatlas.org/resources/2017-atlas.html.
2. Morrison M, Hendrieckx C, Nankervis A, Audehm R, Farrell K, Houvardsa E, et al. Factors associated with attendance for pre-pregnancy care and reasons for non-attendance among women with diabetes. Diabetes Res Clin Pract. 2018; 142: 269-275.
3. Miko E, Csaszar A, Bodis J, Kovacs K. The Maternal-Fetal Gut Microbiota Axis: Physiological Changes, Dietary Influence, and Modulation Possibilities. Life (Basel). 2022; 12(3): 424.
4. Murphy HR, Howgate C, O'Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021; 9(3): 153-164.
5. Hart BN, Shubrook JH, Mason T. Pregestational Diabetes and Family Planning. Clin Diabetes. 2021; 39(3): 323-328.